Antiinflammatory strategies, not just B cell depletion, are required for optimal therapy for severe proliferative lupus nephritis: comment on the article by Rovin et al

Arthritis Rheum. 2012 Oct;64(10):3486; author reply 3486. doi: 10.1002/art.34617.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Lupus Nephritis / drug therapy*
  • Male

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents